Top Abstract Purchase Related
Home
>
Node
>
Subnode

Nutritional management of patients with intestinal graft-versus-host disease

Gauvreau, J.M.; Lenssen, P.; Cheney, C.L.; Aker, S.N.; Hutchinson, M.L.; Barale, K.V.

Journal of the American Dietetic Association 79(6): 673-677

1981

ISSN/ISBN: 0002-8223
PMID: 6796619
Document Number: 173605
Gastrointestinal Graft-Versus-Host Disease (GI GVHD) may occur after bone marrow transplantation for the treatment of acute leucaemia or aplastic anaemia. The resulting GI damage results in symptoms including changed intestinal mobility, malabsorption and protein-losing enteropathy. A five-phase nutritional programme was developed to supply adequate nutrient support, promote intestinal healing, reduce GI symptoms and satisfy individual dietary preferences. The patient and family are integrally involved in the dietary planning and care. Dietary compliance is promoted through the use of nutrition education materials which explain GI GVHD and provide nutritional guidelines and their use.

Document emailed within 1 workday
Secure & encrypted payments

Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Hiroyasu, S.; Shiraishi, M.; Koji, T.; Mamadi, T.; Sugawa, H.; Tomori, H.; Muto, Y. 1999: Analysis of Fas system in pulmonary injury of graft-versus-host disease after rat intestinal transplantation Transplantation 68(7): 933-938
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Spaner, D.; Lowsky, R.; Fyles, G.; Lipton, J.H.; Banerjee, D.; Ng, C.M.; Wade, J.A.; Messner, H.A. 1998: Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient Transplantation 66(9): 1251-1253
Chen, Y.-B. 2019: New treatment options for the management of acute graft-versus-host disease Clinical Advances in Hematology and Oncology: H&o 17(9): 482-485
Price, B.A.; Cumberland, N.S.; Ingham Clark, C.L.; Malcolm, P.; Crane, P.W.; Lear, P.A.; Wood, R.F. 1992: Changes in small intestinal microflora following small bowel transplantation in the rat and bacterial translocation in rejection and graft-versus-host disease Transplantation Proceedings 24(3): 1194
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Dey, B.; Yang, Y.G.; Preffer, F.; Shimizu, A.; Swenson, K.; Dombkowski, D.; Sykes, M. 1999: The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model Transplantation 68(1): 141-149
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Li, Q.-h.; Du, X.; Geng, S.-x.; Weng, J.-y.; Guo, R.; Lu, Z.-s.; Lin, W.; Huang, Z.-l. 2007: JAK3 mRNA level in graft versus host disease patients: a preliminary study Zhonghua Yi Xue Za Zhi 87(28): 1981-1983
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Dale, B.M.; Atkinson, K.; Kotasek, D.; Biggs, J.C.; Sage, R.E. 1989: Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants Transplantation Proceedings 21(5): 3816-3817
Michallet, M.; Corront, B.; Bosson, J.L.; Molina, L.; Peissel, B.; Maraninchi, D.; Reiffers, J.; Chabannon, C.; Gaspard, M.H.; Stoppa, A.M. 1991: Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients Bone Marrow Transplantation 8(1): 13-17
Deeg, H.J.; Spitzer, T.R.; Cottler-Fox, M.; Cahill, R.; Pickle, L.W. 1991: Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis Bone Marrow Transplantation 7(3): 193-198
Klingemann, H.G.; Phillips, G.L. 1990: Double negative (CD4/CD8) T cell receptor alpha/beta positive lymphocytes in patients with graft-versus-host disease Bone Marrow Transplantation 5(5): 364